OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
February 02, 2021
Outsourcing partners can provide a multitude of advantages in the development of drug delivery solutions, including those designed for targeted patient populations.
Collaboration between equipment suppliers and users is leading to innovation and optimization in biopharmaceutical manufacturing.
For drug sponsors that are considering building their own manufacturing facilities, an expert project team is crucial.
CDMOs address the unique challenges of liquid and lyophilized forms as well as preparing for the large capacity needed for COVID-19 vaccines.
February 01, 2021
Nexelis’ recent acquisition of GSK’s Marburg, Germany-based vaccines clinical bioanalytical laboratory expands its bioanalytical capabilities.
The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.
Best practices can help ensure supply chain flexibility and viability for biologic drugs in clinical trials.
Contract development and manufacturing organizations provide vital services to rush COVID-19 vaccines to patients.
January 05, 2021
Vendors are finding ways to address the increasingly complex analytical challenges in the biopharmaceutical industry to further biotherapeutic development.
January 03, 2021
Biopharma looks to deliver on COVID-19 vaccines and other promising therapies.